Altimmune, Inc. (ALT) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
ALT currently has 124M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 78.76% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 13, 2026 |
10-Q filing | 124.5M shares outstanding |
120M | 0 |
| Jan 28, 2026 |
8-K filing: Altimmune, Inc. entered into a Securities Purchase Agreement for a registered direct offering of 12,397,920 shares of common stock and pre-funded warrants to purchase up to 4,647,534 additional shares, with gross proceeds of approximately $75 million before expenses. ($75.0M proceeds) |
81M | 0 |
| Nov 13, 2025 |
S-3/A filing: The filing is an S-3/A form, indicating an amendment to a previously filed S-3 registration statement, concerning the offering of securities for general corporate purposes. |
81M | 0 |
| Nov 06, 2025 |
S-3 filing: This is a financial document parser specializing in SEC filings. The filing is an S-3 form filed on 2025-11-06. |
81M | 0 |
| Nov 06, 2025 |
10-Q filing | 89.4M shares outstanding |
89M | 0 |
| Aug 12, 2025 |
10-Q filing | 81.5M shares outstanding |
81M | 0 |
| May 13, 2025 |
10-Q filing | 75.5M shares outstanding |
76M | 4.2M |
| Feb 27, 2025 |
10-K filing | 71.0M shares outstanding |
71M | 8.7M |
| Feb 27, 2025 |
S-3 filing: The company is offering shares of its common stock through an at-the-market offering for up to $150 million, with the intention of using the net proceeds for working capital and general corporate purposes. |
72M | 7.4M |
| Nov 12, 2024 |
10-Q filing | 71.1M shares outstanding |
71M | 0 |
| Aug 08, 2024 |
10-Q filing | 70.9M shares outstanding |
71M | 0 |
| May 09, 2024 |
10-Q filing | 70.8M shares outstanding |
71M | 0 |
| Mar 27, 2024 |
10-K filing | 70.7M shares outstanding |
71M | 0 |
| Nov 07, 2023 |
10-Q filing | 53.6M shares outstanding |
54M | 1.6M |
| Aug 10, 2023 |
10-Q filing | 50.7M shares outstanding |
51M | 4.5M |
| May 11, 2023 |
10-Q filing | 50.1M shares outstanding |
50M | 5.1M |
| Feb 28, 2023 |
10-K filing | 46.9M shares outstanding |
47M | 8.3M |
| Nov 10, 2022 |
10-Q filing | 49.3M shares outstanding |
49M | 5.9M |
| Aug 11, 2022 |
10-Q filing | 47.5M shares outstanding |
48M | 7.7M |
| May 12, 2022 |
10-Q filing | 44.0M shares outstanding |
44M | 11M |
| Mar 15, 2022 |
10-K filing | 41.3M shares outstanding |
41M | 14M |
| Nov 09, 2021 |
10-Q filing | 39.7M shares outstanding |
40M | 15M |
| Aug 10, 2021 |
10-Q filing | 39.7M shares outstanding |
40M | 16M |
| May 17, 2021 |
10-Q filing | 38.4M shares outstanding |
38M | 17M |
| Feb 25, 2021 |
10-K filing | 37.2M shares outstanding |
37M | 18M |
| Dec 31, 2020 |
S-3 filing: The company may offer up to $250,000,000 of any combination of common stock, preferred stock, debt securities, warrants and/or units. |
33M | 22M |
| Nov 09, 2020 |
10-Q filing | 33.1M shares outstanding |
33M | 0 |
| Aug 11, 2020 |
10-Q filing | 32.9M shares outstanding |
33M | 0 |
| May 13, 2020 |
10-Q filing | 15.5M shares outstanding |
16M | 0 |
| Mar 27, 2020 |
10-K filing | 15.4M shares outstanding |
15M | 0 |